ScholarIQanswers from OpenAlex
Japanese Foundation For Cancer Research
InstitutionResearch output, impact & collaborations
Japanese Foundation For Cancer Research is a institution indexed in ScholarIQ from OpenAlex.
What is known about Japanese Foundation For Cancer Research?
ScholarIQrecord summary
Japanese Foundation For Cancer Research is a research organisation in Tokyo, JP. OpenAlex records 10,816 works and 1,126,409 citations for it. 2,061 researchers list it as their most recent affiliation.
How many works does Japanese Foundation For Cancer Research have?
ScholarIQindexed works
Japanese Foundation For Cancer Research has 10,816 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Japanese Foundation For Cancer Research have?
ScholarIQcitation count
Japanese Foundation For Cancer Research has 1,126,409 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Japanese Foundation For Cancer Research?
ScholarIQresearcher count
Japanese Foundation For Cancer Research has 2,061 researchers in the ScholarIQ index.
What is the average h-index at Japanese Foundation For Cancer Research?
ScholarIQavg h-index
Japanese Foundation For Cancer Research has an average h-index of 66 in OpenAlex.
What is the ROR of Japanese Foundation For Cancer Research?
ScholarIQror
The ROR for Japanese Foundation For Cancer Research is on the source record.
What is the OpenAlex record for Japanese Foundation For Cancer Research?
ScholarIQopenalex
The OpenAlex for Japanese Foundation For Cancer Research is on the source record.
What is the Wikidata of Japanese Foundation For Cancer Research?
ScholarIQwikidata
The Wikidata for Japanese Foundation For Cancer Research is on the source record.
Who are the most-cited researchers behind Japanese Foundation For Cancer Research?
ScholarIQtop researchers by citations
What are the most-cited papers on Japanese Foundation For Cancer Research?
ScholarIQmost cited works
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)
Masamichi Yokoe, Jiro Hata, Tadahiro Takada, Steven M. Strasberg, Horacio J. Asbun, Go Wakabayashi, Kazuto Kozaka, Itaru Endo, Daniel J. Deziel, Fumihiko Miura, Kohji Okamoto, Tsann‐Long Hwang, Wayne Shih‐Wei Huang, Chen‐Guo Ker, Miin‐Fu Chen, Ho‐Seong Han, Yoo‐Seok Yoon, In‐Seok Choi, Dong Sup Yoon, Yoshinori Noguchi, Satoru Shikata, Tomohiko Ukai, Ryota Higuchi, Toshifumi Gabata, Yasuhisa Mori, Yukio Iwashita, Taizo Hibi, P. Jagannath, Eduard Jonas, Kui‐Hin Liau, Christos Dervenis, Dirk J. Gouma, Daniel Cherqui, Giulio Belli, O. James Garden, Mariano Giménez, Eduardo de Santibáñes, Kenji Suzuki, Akiko Umezawa, Avinash Supe, Henry A. Pitt, Harjit Singh, Angus C. W. Chan, Wan Yee Lau, Anthony Yuen Bun Teoh, Goro Honda, Atsushi Sugioka, Koji Asai, Harumi Gomi, Takao Itoi, Seiki Kiriyama, Masahiro Yoshida, Toshihiko Mayumi, Naoki Matsumura, Hiromi Tokumura, Seigo Kitano, Koichi Hirata, Kazuo Inui, Yoshinobu Sumiyama, Masakazu Yamamoto
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Young Lim Choi, Manabu Soda, Yoshihiro Yamashita, Toshihide Ueno, Junpei Takashima, Takahiro Nakajima, Yasushi Yatabe, Kengo Takeuchi, Toru Hamada, Hidenori Haruta, Yuichi Ishikawa, Hideki Kimura, Tetsuya Mitsudomi, Yoshiro Tanio, Hiroyuki Mano
Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis
Kohji Okamoto, Kenji Suzuki, Tadahiro Takada, Steven M. Strasberg, Horacio J. Asbun, Itaru Endo, Yukio Iwashita, Taizo Hibi, Henry A. Pitt, Akiko Umezawa, Koji Asai, Ho‐Seong Han, Tsann‐Long Hwang, Yasuhisa Mori, Yoo‐Seok Yoon, Wayne Shih‐Wei Huang, Giulio Belli, Christos Dervenis, Masamichi Yokoe, Seiki Kiriyama, Takao Itoi, P. Jagannath, O. James Garden, Fumihiko Miura, Masafumi Nakamura, Akihiko Horiguchi, Go Wakabayashi, Daniel Cherqui, Eduardo de Santibáñes, Satoru Shikata, Yoshinori Noguchi, Tomohiko Ukai, Ryota Higuchi, Keita Wada, Goro Honda, Avinash Supe, Masahiro Yoshida, Toshihiko Mayumi, Dirk J. Gouma, Daniel J. Deziel, Kui‐Hin Liau, Miin‐Fu Chen, Kazunori Shibao, Keng‐Hao Liu, Cheng‐Hsi Su, Angus C. W. Chan, Dong Sup Yoon, In‐Seok Choi, Eduard Jonas, Xiaoping Chen, Sheung Tat Fan, Chen‐Guo Ker, Mariano Giménez, Seigo Kitano, Masafumi Inomata, Koichi Hirata, Kazuo Inui, Yoshinobu Sumiyama, Masakazu Yamamoto
Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos)
Seiki Kiriyama, Kazuto Kozaka, Tadahiro Takada, Steven M. Strasberg, Henry A. Pitt, Toshifumi Gabata, Jiro Hata, Kui‐Hin Liau, Fumihiko Miura, Akihiko Horiguchi, Keng‐Hao Liu, Cheng‐Hsi Su, Keita Wada, P. Jagannath, Takao Itoi, Dirk J. Gouma, Yasuhisa Mori, Shuntaro Mukai, Mariano Giménez, Wayne Shih‐Wei Huang, Myung‐Hwan Kim, Kohji Okamoto, Giulio Belli, Christos Dervenis, Angus C. W. Chan, Wan Yee Lau, Itaru Endo, Harumi Gomi, Masahiro Yoshida, Toshihiko Mayumi, Todd H. Baron, Eduardo de Santibáñes, Anthony Yuen Bun Teoh, Tsann‐Long Hwang, Chen‐Guo Ker, Miin‐Fu Chen, Ho‐Seong Han, Yoo‐Seok Yoon, In‐Seok Choi, Dong Sup Yoon, Ryota Higuchi, Seigo Kitano, Masafumi Inomata, Daniel J. Deziel, Eduard Jonas, Koichi Hirata, Yoshinobu Sumiyama, Kazuo Inui, Masakazu Yamamoto
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma
Mamiko Sakata‐Yanagimoto, Terukazu Enami, Kenichi Yoshida, Yuichi Shiraishi, Ryohei Ishii, Y. Miyake, Hideharu Muto, Naoko Tsuyama, Aiko Sato‐Otsubo, Yusuke Okuno, Seiji Sakata, Yuhei Kamada, Rie Nakamoto-Matsubara, Nguyen Bich Tran, Koji Izutsu, Yusuke Sato, Yasunori Ohta, Junichi Furuta, Seiichi Shimizu, Takuya Komeno, Yuji Sato, Takayoshi Ito, Masayuki Noguchi, Emiko Noguchi, Masashi Sanada, Kenichi Chiba, Hiroko Tanaka, Kazumi Suzukawa, Toru Nanmoku, Yuichi Hasegawa, Osamu Nureki, Satoru Miyano, Naoya Nakamura, Kengo Takeuchi, Seishi Ogawa, Shigeru Chiba
How much of the research on Japanese Foundation For Cancer Research is open access?
ScholarIQopen access share
75%OPEN ACCESS